We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rhizopus microsporus as Causative Agent of Mucormycosis in COVID-19 Patient.
- Authors
Sedaghatalab, Moslem; Nouripour-Sisakht, Sadegh; Cheraghzadeh, Seyed R.; Sabz, Gholamabas; Gharaghani, Maral
- Abstract
Background: The pandemic of coronavirus disease (COVID-19) emerged as a fatal infection, especially in immunocompromised patients. Currently, this infection is managed with systemic corticosteroids. Co-infection of COVID-19 with opportunistic fungi is increasingly recognized. Methods: We describe a case of rhino-cerebral mucormycosis 12 days following severe COVID-19 in a diabetic patient. Results: He received 50 mg amphotericin B and surgical debridement. The patient's symptoms improved following medical and surgical intervention. Conclusions: Mucormycosis is an uncommon but serious infection that complicates the course of severe COVID-19. Subjects with diabetes mellitus and multiple risk factors may be at a higher risk for developing mucormycosis.
- Subjects
MUCORMYCOSIS; COVID-19; EMERGING infectious diseases; COVID-19 pandemic; RHIZOPUS; AMPHOTERICIN B
- Publication
Clinical Laboratory, 2022, Vol 68, Issue 12, p2564
- ISSN
1433-6510
- Publication type
Article
- DOI
10.7754/Clin.Lab.2022.220232